Company / Shareholders' Equity
Valion Bio, Inc. Shareholders' Equity History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$3.6M
FY2024
5-year range
$3.6M / $13.3M
FY2022-FY2024
Trend
-1.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $13M to $4M over the past 2 years.
Based on SEC 10-K filings.
$4M in FY2024.
Declined from $13M to $4M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, shareholders' equity decreased 1.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score -10.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $3.6M | -1.4% |
| FY2023 | $3.6M | -72.6% |
| FY2022 | $13.3M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026